TY  - JOUR

T1  - Phase II randomised placebo controlled neoadjuvant chemotherapy study of nintedanib with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer.

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2015.33.15_suppl.tps4574

PY  - 2015/01/01

AU  - Hussain SA

AU  - Jackson R

AU  - Shields A

AU  - Dickinson L

AU  - Cornford P

AU  - Jones RJ

AU  - Lester JF

AU  - Chester JD

AU  - Birtle AJ

AU  - Powles T

AU  - Crabb SJ et al

ED  - 

DO  - DOI: 10.1200/jco.2015.33.15_suppl.tps4574

PB  - American Society of Clinical Oncology (ASCO)

VL  - 33

IS  - 15_suppl

SP  - TPS4574

EP  - TPS4574

Y2  - 2025/12/05

ER  -